vs
Compass Diversified Holdings（CODI）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Compass Diversified Holdings的1.3倍（$622.0M vs $468.6M），Royalty Pharma plc净利率更高（34.4% vs -16.8%，领先51.3%），Royalty Pharma plc同比增速更快（4.8% vs -5.1%），过去两年Compass Diversified Holdings的营收复合增速更高（6.8% vs 4.6%）
Compass Diversified Holdings是一家上市控股公司，专注于收购和运营中端市场企业，业务覆盖消费品、工业制造、户外休闲、食品饮料等多个领域，通过与被投企业管理团队合作，推动长期运营增长与价值创造，主要服务北美市场。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CODI vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.3倍
$468.6M
营收增速更快
RPRX
高出9.9%
-5.1%
净利率更高
RPRX
高出51.3%
-16.8%
两年增速更快
CODI
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $468.6M | $622.0M |
| 净利润 | $-78.8M | $214.2M |
| 毛利率 | 43.1% | — |
| 营业利润率 | 9.8% | 62.4% |
| 净利率 | -16.8% | 34.4% |
| 营收同比 | -5.1% | 4.8% |
| 净利润同比 | -14.4% | 2.9% |
| 每股收益（稀释后） | $-0.91 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CODIRPRX
| Q4 25 | $468.6M | $622.0M | ||
| Q3 25 | $472.6M | $609.3M | ||
| Q2 25 | $478.7M | $578.7M | ||
| Q1 25 | $453.8M | $568.2M | ||
| Q4 24 | $493.9M | $593.6M | ||
| Q3 24 | $456.6M | $564.7M | ||
| Q2 24 | $426.7M | $537.3M | ||
| Q1 24 | $410.8M | $568.0M |
净利润CODIRPRX
| Q4 25 | $-78.8M | $214.2M | ||
| Q3 25 | $-74.0M | $288.2M | ||
| Q2 25 | $-51.2M | $30.2M | ||
| Q1 25 | $-30.0M | $238.3M | ||
| Q4 24 | $-68.9M | $208.2M | ||
| Q3 24 | $-36.0M | $544.0M | ||
| Q2 24 | $-73.1M | $102.0M | ||
| Q1 24 | $-56.2M | $4.8M |
毛利率CODIRPRX
| Q4 25 | 43.1% | — | ||
| Q3 25 | 44.0% | — | ||
| Q2 25 | 43.6% | — | ||
| Q1 25 | 43.2% | — | ||
| Q4 24 | 38.6% | — | ||
| Q3 24 | 43.1% | — | ||
| Q2 24 | 44.1% | — | ||
| Q1 24 | 42.6% | — |
营业利润率CODIRPRX
| Q4 25 | 9.8% | 62.4% | ||
| Q3 25 | -2.3% | 70.1% | ||
| Q2 25 | -5.7% | 36.3% | ||
| Q1 25 | 0.8% | 94.0% | ||
| Q4 24 | -3.8% | 60.9% | ||
| Q3 24 | 1.8% | — | ||
| Q2 24 | 1.8% | 50.2% | ||
| Q1 24 | -2.9% | -13.0% |
净利率CODIRPRX
| Q4 25 | -16.8% | 34.4% | ||
| Q3 25 | -15.7% | 47.3% | ||
| Q2 25 | -10.7% | 5.2% | ||
| Q1 25 | -6.6% | 41.9% | ||
| Q4 24 | -13.9% | 35.1% | ||
| Q3 24 | -7.9% | 96.3% | ||
| Q2 24 | -17.1% | 19.0% | ||
| Q1 24 | -13.7% | 0.8% |
每股收益（稀释后）CODIRPRX
| Q4 25 | $-0.91 | $0.49 | ||
| Q3 25 | $-1.21 | $0.67 | ||
| Q2 25 | $-0.88 | $0.07 | ||
| Q1 25 | $-0.59 | $0.55 | ||
| Q4 24 | $-0.57 | $0.46 | ||
| Q3 24 | $-0.62 | $1.21 | ||
| Q2 24 | $-1.12 | $0.23 | ||
| Q1 24 | $-1.52 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $68.0M | $618.7M |
| 总债务越低越好 | $1.9B | $9.0B |
| 股东权益账面价值 | $442.0M | $9.7B |
| 总资产 | $3.0B | $19.6B |
| 负债/权益比越低杠杆越低 | 4.25× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CODIRPRX
| Q4 25 | $68.0M | $618.7M | ||
| Q3 25 | $61.1M | $938.9M | ||
| Q2 25 | $73.8M | $631.9M | ||
| Q1 25 | $146.2M | $1.1B | ||
| Q4 24 | $59.7M | $929.0M | ||
| Q3 24 | $64.9M | $950.1M | ||
| Q2 24 | $61.5M | $1.8B | ||
| Q1 24 | $59.5M | $843.0M |
总债务CODIRPRX
| Q4 25 | $1.9B | $9.0B | ||
| Q3 25 | $1.9B | $8.9B | ||
| Q2 25 | $1.9B | $8.0B | ||
| Q1 25 | $1.9B | $7.6B | ||
| Q4 24 | $1.8B | $7.6B | ||
| Q3 24 | $1.8B | $7.6B | ||
| Q2 24 | $1.7B | $7.6B | ||
| Q1 24 | $1.7B | $6.1B |
股东权益CODIRPRX
| Q4 25 | $442.0M | $9.7B | ||
| Q3 25 | $519.2M | $9.6B | ||
| Q2 25 | $601.9M | $9.5B | ||
| Q1 25 | $680.7M | $9.8B | ||
| Q4 24 | $678.6M | $10.3B | ||
| Q3 24 | $672.2M | $10.3B | ||
| Q2 24 | $711.3M | $9.8B | ||
| Q1 24 | $799.7M | $9.9B |
总资产CODIRPRX
| Q4 25 | $3.0B | $19.6B | ||
| Q3 25 | $3.2B | $19.3B | ||
| Q2 25 | $3.3B | $18.3B | ||
| Q1 25 | $3.4B | $17.6B | ||
| Q4 24 | $3.3B | $18.2B | ||
| Q3 24 | $3.3B | $18.0B | ||
| Q2 24 | $3.2B | $17.7B | ||
| Q1 24 | $3.3B | $16.1B |
负债/权益比CODIRPRX
| Q4 25 | 4.25× | 0.92× | ||
| Q3 25 | 3.62× | 0.93× | ||
| Q2 25 | 3.09× | 0.84× | ||
| Q1 25 | 2.73× | 0.78× | ||
| Q4 24 | 2.61× | 0.74× | ||
| Q3 24 | 2.64× | 0.74× | ||
| Q2 24 | 2.42× | 0.78× | ||
| Q1 24 | 2.15× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $47.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $36.9M | — |
| 自由现金流率自由现金流/营收 | 7.9% | — |
| 资本支出强度资本支出/营收 | 2.2% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $-51.1M | — |
8季度趋势，按日历期对齐
经营现金流CODIRPRX
| Q4 25 | $47.0M | $827.1M | ||
| Q3 25 | $10.7M | $702.6M | ||
| Q2 25 | $-35.2M | $364.0M | ||
| Q1 25 | $-29.3M | $596.1M | ||
| Q4 24 | $-16.1M | $742.5M | ||
| Q3 24 | $-48.4M | $703.6M | ||
| Q2 24 | $-61.3M | $658.2M | ||
| Q1 24 | $-25.4M | $664.6M |
自由现金流CODIRPRX
| Q4 25 | $36.9M | — | ||
| Q3 25 | $481.0K | — | ||
| Q2 25 | $-46.0M | — | ||
| Q1 25 | $-42.4M | — | ||
| Q4 24 | $-39.0M | — | ||
| Q3 24 | $-63.5M | — | ||
| Q2 24 | $-72.2M | — | ||
| Q1 24 | $-33.1M | — |
自由现金流率CODIRPRX
| Q4 25 | 7.9% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | -9.6% | — | ||
| Q1 25 | -9.4% | — | ||
| Q4 24 | -7.9% | — | ||
| Q3 24 | -13.9% | — | ||
| Q2 24 | -16.9% | — | ||
| Q1 24 | -8.1% | — |
资本支出强度CODIRPRX
| Q4 25 | 2.2% | — | ||
| Q3 25 | 2.2% | — | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 4.6% | — | ||
| Q3 24 | 3.3% | — | ||
| Q2 24 | 2.6% | — | ||
| Q1 24 | 1.9% | — |
现金转化率CODIRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CODI
| Other | $119.5M | 26% |
| A5.11Tactical | $113.9M | 24% |
| Sterno Products | $85.9M | 18% |
| Altor | $60.8M | 13% |
| The Honey Pot | $36.0M | 8% |
| Arnold | $25.4M | 5% |
| Velocity Outdoor | $18.7M | 4% |
| Lugano | $8.3M | 2% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
